| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:1799-1806.)
© 2006 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Department of Cardiology and Angiology (P.K., L.F., M.Z., S.Z., M.P., T.A., G.B., T.W.) and Department of Nuclear Medicine (M.S.), Hospital of the University of Muenster, Muenster, Germany; Interdisciplinary Center for Clinical Research (P.K., L.F., M.Z., H.W., M.S., T.W.), University of Muenster, Muenster, Germany; Center for Cardiovascular Research (H.W., P.R.), Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Experimental Physics (K.-H.H.), University of Wuerzburg, Wuerzburg, Germany; and Department of Pathology (H.A.B.) and Institute of Pathophysiology (B.L.), Hospital of the University of Duisburg-Essen, Duisburg-Essen, Germany.
Correspondence to Paulus Kirchhof, MD, Department of Cardiology and Angiology, Hospital of the University of Muenster, Albert-Schweitzer-Straße 33, D-48149 Münster, Germany. E-mail kirchhp{at}uni-muenster.de
Received March 12, 2006; revision received July 17, 2006; accepted July 21, 2006.
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disorder that causes sudden death and right ventricular heart failure in the young. Clinical data suggest that competitive sports may provoke ARVC in susceptible persons. Genetically, loss-of-function mutations in desmosomal proteins (plakophilin, desmoplakin, or plakoglobin) have been associated with ARVC. To test the hypothesis that reduced desmosomal protein expression causes ARVC, we studied the cardiac effects of heterozygous plakoglobin deficiency in mice.
Methods and Results Ten-month-old heterozygous plakoglobin-deficient mice (plakoglobin+/) had increased right ventricular volume, reduced right ventricular function, and spontaneous ventricular ectopy (all P<0.05). Left ventricular size and function were not altered. Isolated, perfused plakoglobin+/ hearts had spontaneous ventricular tachycardia of right ventricular origin and prolonged right ventricular conduction times compared with wild-type hearts. Endurance training accelerated the development of right ventricular dysfunction and arrhythmias in plakoglobin+/ mice. Histology and electron microscopy did not identify right ventricular abnormalities in affected animals.
Conclusions Heterozygous plakoglobin deficiency provokes ARVC. Manifestation of the phenotype is accelerated by endurance training. This suggests a functional role for plakoglobin and training in the development of ARVC.
This article has been cited by other articles:
![]() |
M. D. McCauley and X. H. T. Wehrens Animal models of arrhythmogenic cardiomyopathy Dis. Model. Mech., November 1, 2009; 2(11-12): 563 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pilichou, C. A. Remme, C. Basso, M. E. Campian, S. Rizzo, P. Barnett, B. P. Scicluna, B. Bauce, M. J.B. van den Hoff, J. M.T. de Bakker, et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy J. Exp. Med., August 3, 2009; 206(8): 1787 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al. Morphologic Variants of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Genetics-Magnetic Resonance Imaging Correlation Study J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. La Gerche, A. J. Taylor, and D. L. Prior Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions. J. Am. Coll. Cardiol. Img., March 1, 2009; 2(3): 350 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J.D. Boukens, V. M. Christoffels, R. Coronel, and A. F.M. Moorman Developmental Basis for Electrophysiological Heterogeneity in the Ventricular and Outflow Tract Myocardium As a Substrate for Life-Threatening Ventricular Arrhythmias Circ. Res., January 2, 2009; 104(1): 19 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sen-Chowdhry, P. Syrris, and W. J. McKenna Role of Genetic Analysis in the Management of Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1813 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al. Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Marcus and J. A. Towbin The Mystery of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: From Observation to Mechanistic Explanation Circulation, October 24, 2006; 114(17): 1794 - 1795. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |